論文

査読有り
2013年

Lack of goal attainment regarding the low-density lipoprotein cholesterol level in the management of type 2 diabetes mellitus.

Internal medicine (Tokyo, Japan)
  • Masaya Hosokawa
  • ,
  • Akihiro Hamasaki
  • ,
  • Kazuaki Nagashima
  • ,
  • Shinichi Harashima
  • ,
  • Kentaro Toyoda
  • ,
  • Yoshihito Fujita
  • ,
  • Norio Harada
  • ,
  • Yuko Nakahigashi
  • ,
  • Shimpei Fujimoto
  • ,
  • Nobuya Inagaki

52
21
開始ページ
2409
終了ページ
15
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.2169/internalmedicine.52.0599
出版者・発行元
JAPAN SOC INTERNAL MEDICINE

OBJECTIVE: The management of diabetes mellitus includes controlling the blood glucose level, body weight, blood pressure and serum lipid level. The coexistence of diabetes and a high low-density lipoprotein cholesterol (LDL-C) level promotes atherosclerosis of the coronary arteries and increases the risk of coronary artery disease (CAD). We compared the rates of attainment of LDL-C goals in type 2 diabetes patients receiving primary and secondary prevention therapy, the former without a history of CAD and the latter with a history of CAD. Because patients receiving secondary prevention are at greater risk of coronary events, LDL-C management is especially important in this group. This study was designed to determine how frequently diabetic patients attain their LDL-C goals and identify the reasons for the lack of attainment. METHODS: The groups were distinguished according to the patients' medical records. Contributory factors for the patients not achieving their goals were recorded in a questionnaire filled out by each patient's physician. RESULTS: The overall attainment rate in both groups was 61%. The most frequent impediment in both groups was "an LDL-C level above or below the goal at every hospital visit" followed by "continuously sufficient effects of dietary therapy only" and the "management of LDL-C by other departments or hospitals," the latter reflecting the increasing problems of polydisease and polypharmacy in diabetes care. CONCLUSION: Polydisease and polypharmacy issues in diabetes patients with a history of CAD constitute a growing barrier to medication adherence and the attainment of treatment goals.

リンク情報
DOI
https://doi.org/10.2169/internalmedicine.52.0599
CiNii Articles
http://ci.nii.ac.jp/naid/130003383678
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/24190144
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000327938400003&DestApp=WOS_CPL
ID情報
  • DOI : 10.2169/internalmedicine.52.0599
  • ISSN : 0918-2918
  • eISSN : 1349-7235
  • CiNii Articles ID : 130003383678
  • PubMed ID : 24190144
  • Web of Science ID : WOS:000327938400003

エクスポート
BibTeX RIS